Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337486 | PMC |
http://dx.doi.org/10.1007/pl00012504 | DOI Listing |
Environ Res
January 2025
Department of Environmental Engineering, Kyungpook National University, Daegu, South Korea.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).
View Article and Find Full Text PDFGeriatr Psychol Neuropsychiatr Vieil
September 2024
CMRR CHU Toulouse, IHU Health Age, Toulouse, UMR 1297 CERPOP.
The growing prevalence of the Alzheimer's disease (AD) is an increasing public health concern that led to French recommendations for timely AD diagnosis and patient management as well as a territorial coverage of specialized structures [Memory Centers including Resources and Memory Research Centers (RMRC) and Memory Consultations (MC)]. In view of the potential availability of Disease Modifying Therapies (DMTs), this French observatory aimed to describe the current organization of the Memory Centers, and the care pathway of patients suffering from early AD. Overall, 12 of the 28 RMRC and 44 of the 250 MC solicited by the Federation of Memory Centers participated in this study.
View Article and Find Full Text PDFGeriatr Psychol Neuropsychiatr Vieil
September 2024
Metacognition, the ability to monitor and regulate one's own cognitive processes, is subject to varying degrees of modification in patients suffering from neurodegenerative diseases. The literature suggests the existence of dissociations within metacognitive abilities, with some patients exhibiting, for example, specific impairments in self-assessing their memory (and not other cognitive domains). The specific assessment of metacognition in patients' social-cognitive abilities is underdeveloped, although it has significant implications for both clinical and theoretical purposes.
View Article and Find Full Text PDFJ Relig Ethics
March 2024
Institute of Philosophy at Jagiellonian University in Kraków (Poland) and head of the Interdisciplinary Centre for Ethics at Jagiellonian University, where he leads the project BIOUNCERTAINTY funded by a European Research Council (ERC) Starting Grant.
A dogma accepted in many ethical, religious, and legal frameworks is that the reasons behind conscientious objection (CO) in healthcare cannot be evaluated or judged by any institution because conscience is individual and autonomous. This paper shows that this background view is mistaken: the requirement to reveal and explain the reasons for conscientious objection in healthcare is ethically justified and legally desirable. Referring to real healthcare cases and legal regulations, this paper argues that these reasons should be evaluated either ex ante or ex post and defends novel conceptual claims that have not been analyzed in the debates on CO.
View Article and Find Full Text PDFQuant Imaging Med Surg
January 2025
Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Fatty acid can potentially serve as biomarker for evaluating metabolic disorder and inflammation condition, and quantifying the double bonds is the key for revealing fatty acid information. This study presents an assessment of a deep learning approach utilizing deep image prior (DIP) for the quantification of double bonds and methylene-interrupted double bonds of triglyceride derived from chemical-shift encoded multi-echo gradient echo images, all achieved without the necessity for network training. The methodology implemented a cost function grounded in signal constraints to continually refine the neural network's parameters on a single slice of images through iterative processes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!